Moderna price target lowered to $69 from $115 at Piper Sandler
Piper Sandler lowered the firm’s price target on Moderna (MRNA) to $69 from $115 and keeps an Overweight rating on the shares. The firm notes ...
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
Moderna plans to prioritize new product approvals and oncology investments, as political concerns over Robert F. Kennedy Jr.'s HHS nomination weigh on vaccine stocks.
These Stocks Moved the Most Today: Applied Materials, Palantir, Tesla, Moderna, Super Micro, Alibaba, Bloom Energy, and More
Applied Materials tumbles after issuing a disappointing fiscal first-quarter outlook, Palantir is transferring its stock listing to the Nasdaq, and Tesla rises following a decline on worries President ...
Moderna upgraded to Hold from Reduce at HSBC
HSBC upgraded Moderna (MRNA) to Hold from Reduce with a $58 price target Don't Miss our Black Friday Offers:Discover the latest stocks ...
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
Super Micro Computer, Inc. SMCI stock tumbled 24.23% after the company recently announced it could not file its quarterly ...
Moderna continues to be the most shorted among S&P 500 healthcare stocks in October
Short interest for healthcare stocks in S&P 500 stayed flat in October vs. September, while Moderna continued to be most ...